Skip to content
1887
Preview this article:

There is no abstract available.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.05298-0
2003-11-01
2026-03-15

Metrics

Loading full text...

Full text loading...

References

  1. Aliff T. B, Maslak P. G, Jurcic J. G, Heaney M. L, Cathcart K. N, Sepkowitz K. A, Weiss M. A. 2003; Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin. Cancer 97:1025–1032 [CrossRef]
    [Google Scholar]
  2. Becker M. J, de Marie S, Willemse D, Verbrugh H. A, Bakker-Woudenberg I. A. J. M. 2000; Quantitative galactomannan detection is superior to PCR in diagnosing and monitoring invasive pulmonary aspergillosis in an experimental rat model. J Clin Microbiol 38:1434–1438
    [Google Scholar]
  3. Conesa D, Rello J, Valles J, Mariscal D, Ferreres J. C. 1995; Invasive aspergillosis: a life-threatening complication of short-term steroid treatment. Ann Pharmacother 29:1235–1237
    [Google Scholar]
  4. Kristan S. S, Kern I, Mušič E. 2002; Invasive pulmonary aspergillosis. Respiration 69:521–525 [CrossRef]
    [Google Scholar]
  5. Meletiadis J, Melchers W. J, Meis J. F, Van Den Hurk P, Jannes G, Verweij P. E. 2003; Evaluation of a polymerase chain reaction reverse hybridization line probe assay for the detection and identification of medically important fungi in bronchoalveolar lavage fluids. Med Mycol 41:65–74 [CrossRef]
    [Google Scholar]
  6. Obayashi T, Yoshida M, Mori T. 10 other authors 1995; Plasma (1→3)-β-d-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 345:17–20 [CrossRef]
    [Google Scholar]
  7. Pittet D, Huguenin T, Dharan S, Sztajzel-Boissard J, Ducel G, Thorens J. B, Auckenthaler R, Chevrolet J. C. 1996; Unusual cause of lethal pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 154:541–544 [CrossRef]
    [Google Scholar]
  8. Teramoto S, Sawaki D, Okada S, Ouchi Y. 2000; Markedly increased plasma (1→3)-β-d-glucan is a diagnostic and therapeutic indicator of Pneumocystis carinii pneumonia in a non-AIDS patient. J Med Microbiol 49:393–394
    [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.05298-0
Loading
/content/journal/jmm/10.1099/jmm.0.05298-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error